title: [The treatment of children with Helicobarter pylory by triple therapy can be shortened without the risk of losing it eradicating efficacy. Letter].
authors.forename: M L
authors.initials: ML
authors.lastname: Cilleruelo
authors.forename: P
authors.initials: P
authors.lastname: Urruzuno
authors.forename: M J
authors.initials: MJ
authors.lastname: Martínez
authors.forename: D
authors.initials: D
authors.lastname: Madruga
authors.forename: M
authors.initials: M
authors.lastname: Sebastián
authors.forename: E
authors.initials: E
authors.lastname: Román
authors.forename: A
authors.initials: A
authors.lastname: Barrio
authors.forename: J
authors.initials: J
authors.lastname: Manzanares
authors.forename: E
authors.initials: E
authors.lastname: Medina
authors.forename: J
authors.initials: J
authors.lastname: Sarría
authors.forename: J C
authors.initials: JC
authors.lastname: Sanz
mesh_terms: D000293:Adolescent; D000658:Amoxicillin / Q000008:administration & dosage / Q000627:therapeutic use*; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D000994:Antitrichomonal Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D004359:Drug Therapy, Combination; D016481:Helicobacter Infections / Q000188:drug therapy* / Q000382:microbiology; D016480:Helicobacter pylori / Q000302:isolation & purification; D006801:Humans; D008795:Metronidazole / Q000008:administration & dosage / Q000627:therapeutic use*; D009942:Organometallic Compounds / Q000008:administration & dosage / Q000627:therapeutic use*; D010406:Penicillins / Q000008:administration & dosage / Q000627:therapeutic use*; D013997:Time Factors
chemical_list: D000900:Anti-Bacterial Agents; D000994:Antitrichomonal Agents; D009942:Organometallic Compounds; D010406:Penicillins; D008795:Metronidazole; D000658:Amoxicillin; C002791:bismuth tripotassium dicitrate